PL2453901T3 - Fukozyloklaktoza jako identyczny z mlekiem kobiecym niestrawny oligosacharyd do leczenia i/lub zapobiegania infekcji wirusowych - Google Patents

Fukozyloklaktoza jako identyczny z mlekiem kobiecym niestrawny oligosacharyd do leczenia i/lub zapobiegania infekcji wirusowych

Info

Publication number
PL2453901T3
PL2453901T3 PL10734570T PL10734570T PL2453901T3 PL 2453901 T3 PL2453901 T3 PL 2453901T3 PL 10734570 T PL10734570 T PL 10734570T PL 10734570 T PL10734570 T PL 10734570T PL 2453901 T3 PL2453901 T3 PL 2453901T3
Authority
PL
Poland
Prior art keywords
fucosyllactose
treating
viral infections
breast milk
preventing viral
Prior art date
Application number
PL10734570T
Other languages
English (en)
Inventor
Bernd Stahl
Alma Jildou Nauta
Johan Garssen
Eric Samain
Sophie Drouillard
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41016877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2453901(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nutricia Nv filed Critical Nutricia Nv
Publication of PL2453901T3 publication Critical patent/PL2453901T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/572—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 cytotoxic response

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pediatric Medicine (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
PL10734570T 2009-07-15 2010-07-12 Fukozyloklaktoza jako identyczny z mlekiem kobiecym niestrawny oligosacharyd do leczenia i/lub zapobiegania infekcji wirusowych PL2453901T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP09165485 2009-07-15
US25645309P 2009-10-30 2009-10-30
EP10734570.4A EP2453901B1 (en) 2009-07-15 2010-07-12 Fucosyllactose as breast milk identical non-digestible oligosaccharide for treating and/or preventing viral infections
PCT/NL2010/050447 WO2011008087A1 (en) 2009-07-15 2010-07-12 Fucosyllactose as breast milk identical non-digestible oligosaccharide with new functional benefit

Publications (1)

Publication Number Publication Date
PL2453901T3 true PL2453901T3 (pl) 2015-03-31

Family

ID=41016877

Family Applications (2)

Application Number Title Priority Date Filing Date
PL10734570T PL2453901T3 (pl) 2009-07-15 2010-07-12 Fukozyloklaktoza jako identyczny z mlekiem kobiecym niestrawny oligosacharyd do leczenia i/lub zapobiegania infekcji wirusowych
PL17204679T PL3342413T3 (pl) 2009-07-15 2010-07-12 Fukozylolaktoza jako identyczny z mlekiem kobiecym niestrawny oligosacharyd do leczenia i/lub zapobiegania biegunce wirusowej

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL17204679T PL3342413T3 (pl) 2009-07-15 2010-07-12 Fukozylolaktoza jako identyczny z mlekiem kobiecym niestrawny oligosacharyd do leczenia i/lub zapobiegania biegunce wirusowej

Country Status (9)

Country Link
US (5) US20120177691A1 (pl)
EP (4) EP4197542A1 (pl)
CN (1) CN102497869B (pl)
BR (1) BR112012000859B1 (pl)
ES (2) ES2904608T3 (pl)
MY (2) MY164674A (pl)
PL (2) PL2453901T3 (pl)
RU (1) RU2530641C2 (pl)
WO (1) WO2011008087A1 (pl)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2453901T3 (pl) 2009-07-15 2015-03-31 Nutricia Nv Fukozyloklaktoza jako identyczny z mlekiem kobiecym niestrawny oligosacharyd do leczenia i/lub zapobiegania infekcji wirusowych
WO2011008086A1 (en) 2009-07-15 2011-01-20 N.V. Nutricia Mixture of non-digestible oligosaccharides for stimulating the immune system
EP2465509A1 (en) 2010-11-23 2012-06-20 Nestec S.A. Oligosaccharide composition for treating acute respiratory tract infections
ES2804258T3 (es) 2010-12-31 2021-02-05 Abbott Lab Procedimientos para reducir la incidencia de estrés oxidativo usando oligosacáridos de leche humana, vitamina C y agentes antiinflamatorios
MY191538A (en) 2010-12-31 2022-06-30 Abbott Lab Human milk oligosaccharides to promote growth of beneficial bacteria
ES2667393T3 (es) 2010-12-31 2018-05-10 Abbott Laboratories Oligosacáridos de leche humana para modular inflamación
CA2822490C (en) 2010-12-31 2020-03-31 Abbott Laboratories Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
CN107019701B (zh) 2010-12-31 2020-07-28 雅培制药有限公司 使用人乳低聚糖来降低婴儿、幼儿或儿童的坏死性小肠结肠炎的发病率的方法
US8802650B2 (en) 2010-12-31 2014-08-12 Abbott Laboratories Methods of using human milk oligosaccharides for improving airway respiratory health
MY166945A (en) 2010-12-31 2018-07-25 Abbott Lab Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated polyunsaturated fatty acids and uses thereof
EP2707379A4 (en) 2011-05-13 2014-10-08 Glycosyn LLC USE OF PURIFIED 2'-FUCOSYLLACTOSIS, 3-FUCOSYLLACTOSIS AND LACTODIFUCOTETRAOSE AS PREBIOTICS
EP2734210B1 (en) 2011-07-22 2017-11-22 Abbott Laboratories Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
CA2846603A1 (en) * 2011-08-29 2013-03-07 Abbott Laboratories Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
EP2830712A1 (en) * 2012-03-27 2015-02-04 Abbott Laboratories Methods for modulating cell-mediated immunity using human milk oligosaccharides
EP2656862A1 (en) 2012-04-24 2013-10-30 The Procter & Gamble Company Substrate comprising one or more human milk oligosaccharides and disposable absorbent article comprising the substrate
ES2572831T3 (es) 2012-09-14 2016-06-02 Abbott Laboratories Composiciones nutricionales para su uso en métodos para modular los niveles de corticosterona en individuos con estrés psicológico
CN105722515A (zh) * 2013-11-15 2016-06-29 雀巢产品技术援助有限公司 用于预防或治疗有风险婴儿或幼儿的urt感染的组合物
WO2015071391A1 (en) * 2013-11-15 2015-05-21 Nestec S.A. Infant formulas containing a 2-fucosylated oligosaccharide for treatment or prevention of influenza infection
US10568896B2 (en) 2013-11-19 2020-02-25 Abbott Laboratories Methods for preventing or mitigating acute allergic responses using human milk oligosaccharides
SG11201608248YA (en) 2014-04-08 2016-10-28 Abbott Lab Methods for enhancing mucosal innate immune responses to and/or detection of pathogens using human milk oligosaccharides
CN114532538A (zh) * 2015-03-05 2022-05-27 雀巢产品有限公司 用于预防或治疗婴儿或幼儿的耳炎或支气管炎的组合物
MX378680B (es) 2015-03-05 2025-03-11 Soc Des Produits Nestle S A Star Composiciones para usar en la prevencion o el tratamiento de infecciones/inflamaciones gastrointestinales en infantes o niños pequeños.
ES2960750T3 (es) * 2015-03-05 2024-03-06 Glycom As Oligosacáridos de la leche humana para el tratamiento de infecciones agudas del aparato respiratorio
WO2016184880A1 (en) * 2015-05-19 2016-11-24 Nestec S.A. Kit-of-parts to identify mother's milk missing fucosyltransferase-2 dependent glycans and feeding doses with said glycans
CN104940925A (zh) * 2015-07-17 2015-09-30 宁波荣安生物药业有限公司 一种人用狂犬病疫苗及其制备方法
EP4477262A3 (en) * 2016-09-07 2025-04-23 Société des Produits Nestlé S.A. Nutritional compositions for infants and/or young children
WO2019031961A1 (en) 2017-08-11 2019-02-14 N.V. Nutricia OLIGOSACCHARIDE OF HUMAN MILK TO IMPROVE PHYSICAL IMMUNE CONDITION
CN107373674A (zh) * 2017-08-25 2017-11-24 西宝生物科技（上海）股份有限公司 一种肿瘤治疗后的营养组合物及其应用
EP3820307A1 (en) * 2018-07-12 2021-05-19 N.V. Nutricia Nutritional composition for improving intestinal barrier integrity, preparation of the composition and method of treatment
CN112384079A (zh) * 2018-07-12 2021-02-19 N·V·努特里奇亚 用于治疗腹泻的营养组合物、其制备和治疗方法
WO2020243371A1 (en) * 2019-05-28 2020-12-03 Massachusetts Institute Of Technology Methods and compositions for modulating immune responses
US20220248739A1 (en) * 2019-05-29 2022-08-11 N.V. Nutricia Non-digestible oligosaccharides for decreased colonic protein fermentation
US20220110985A1 (en) * 2019-06-04 2022-04-14 N.V. Nutricia Nutritional composition comprising 2'fucosyllactose and 3'galactosyllactose
BR112021007254A2 (pt) * 2019-06-04 2021-08-10 N.V. Nutricia composição nutricional para lactentes ou crianças de primeira infância
WO2021115578A1 (en) * 2019-12-10 2021-06-17 N.V. Nutricia Purified non-dairy vegetable protein
CN111011864A (zh) * 2019-12-27 2020-04-17 内蒙古蒙牛乳业（集团）股份有限公司 一种促进肠道健康的营养组分
EP3888661B1 (en) * 2020-03-31 2025-12-17 FrieslandCampina Nederland B.V. Compositions comprising 2 -fucosyllactose to prevent viral infections
EP4260862A4 (en) * 2020-12-11 2024-05-22 Advanced Protein Technologies Corp. Antiviral composition containing fucosyllactose as active ingredient
CN116115623B (zh) * 2022-12-12 2024-02-23 天津市肿瘤医院（天津医科大学肿瘤医院） 2'-岩藻糖基乳糖作为一种抗肿瘤辅助药物的应用
US12527342B2 (en) * 2024-01-12 2026-01-20 Nutifood Nutrition Food Joint Stock Company Supplementary composition containing 2′-fucosyllactose (2′-fl) and fructo-oligosaccharide (FOS) with synergistic effects on the digestive and immune systems for children, and process of manufacturing a children formula containing said supplementary composition

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5002759A (en) * 1989-07-25 1991-03-26 Colgate-Palmolive Company Oligosaccharide inhibition of Streptococcus pyogenes adhesion
US6204431B1 (en) 1994-03-09 2001-03-20 Abbott Laboratories Transgenic non-human mammals expressing heterologous glycosyltransferase DNA sequences produce oligosaccharides and glycoproteins in their milk
DE19701382A1 (de) 1997-01-16 1998-07-23 Nutricia Nv Kohlenhydratmischung
US20020019991A1 (en) 1998-04-30 2002-02-14 Abbott Laboratories Compositions containing an alpha 1,2-fucose linkage and uses thereof
DE19836339B4 (de) 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
EP1261355B1 (en) 2000-03-01 2004-12-01 Société des Produits Nestlé S.A. Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response
FR2814471B1 (fr) * 2000-09-27 2004-12-17 Centre Nat Rech Scient Utilisation de polymeres et d'oligomeres de xyloglucane, et de composes derives, en tant que produits phytosanitaires et biofertilisants
ES2781848T3 (es) * 2003-10-24 2020-09-08 Nutricia Nv Oligosacáridos inmunomoduladores
JP4740866B2 (ja) 2003-10-24 2011-08-03 ナムローゼ フェンノートシャップ ニュートリシア 乳児向けシンバイオティック組成物
EP2497478A3 (en) * 2003-12-05 2012-11-07 Children's Hospital Medical Center Oligosaccaride compositions and use thereof in the treatment of infection
EP1597978A1 (en) 2004-05-17 2005-11-23 Nutricia N.V. Synergism of GOS and polyfructose
PT1629850E (pt) 2004-08-24 2007-08-14 Nutricia Nv Composição nutricional que compreende a administração de oligossacarídeos indigeríveis
CN101123888B (zh) * 2005-02-21 2016-03-23 雀巢技术公司 寡糖混合物
WO2007010084A2 (en) 2005-07-15 2007-01-25 Johannes Savolainen Immunostimulatory oligo- and polysaccharides and uses thereof
EP1776877A1 (en) * 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
WO2007067033A1 (en) 2005-12-06 2007-06-14 N.V. Nutricia Composition containing oligosaccharides for the treatment/ prevention of infections
CN101420966B (zh) * 2006-03-10 2013-07-17 纽崔西亚公司 不可消化的糖用于在出生后给予婴儿最佳开始的用途
WO2007114683A1 (en) 2006-03-30 2007-10-11 N.V. Nutricia Milk oligosaccharides for stimulating the immune system
US9239329B2 (en) * 2006-12-18 2016-01-19 Japan Science And Technology Agency Method of measuring interaction between biomaterial and sugar chain, method of evaluating biomaterial in sugar chain selectivity, method of screening biomaterial, method of patterning biomaterials, and kits for performing these methods
WO2009067000A1 (en) 2007-11-20 2009-05-28 N.V. Nutricia Composition with synbiotics
EP2072052A1 (en) 2007-12-17 2009-06-24 Nestec S.A. Prevention of opportunistic infections in immune-compromised subjects
WO2010143940A1 (en) 2009-06-12 2010-12-16 N.V. Nutricia Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages
WO2011008086A1 (en) 2009-07-15 2011-01-20 N.V. Nutricia Mixture of non-digestible oligosaccharides for stimulating the immune system
PL2453901T3 (pl) 2009-07-15 2015-03-31 Nutricia Nv Fukozyloklaktoza jako identyczny z mlekiem kobiecym niestrawny oligosacharyd do leczenia i/lub zapobiegania infekcji wirusowych
US8802650B2 (en) 2010-12-31 2014-08-12 Abbott Laboratories Methods of using human milk oligosaccharides for improving airway respiratory health
WO2015071391A1 (en) 2013-11-15 2015-05-21 Nestec S.A. Infant formulas containing a 2-fucosylated oligosaccharide for treatment or prevention of influenza infection
AU2014361229A1 (en) 2013-12-12 2016-04-28 Nestec S.A. Synthetic nutritional compositions especially adapted for male and female infants and young children

Also Published As

Publication number Publication date
EP4197542A1 (en) 2023-06-21
EP2453901A1 (en) 2012-05-23
EP3342413A1 (en) 2018-07-04
US20120177691A1 (en) 2012-07-12
CN102497869A (zh) 2012-06-13
WO2011008087A1 (en) 2011-01-20
US20220023418A1 (en) 2022-01-27
BR112012000859A2 (pt) 2018-03-13
RU2530641C2 (ru) 2014-10-10
PL3342413T3 (pl) 2022-03-28
CN102497869B (zh) 2013-11-27
BR112012000859B1 (pt) 2021-08-03
US20160158346A1 (en) 2016-06-09
MY195771A (en) 2023-02-10
RU2012105310A (ru) 2013-08-20
EP3342413B1 (en) 2021-10-20
ES2525565T3 (es) 2014-12-26
ES2904608T3 (es) 2022-04-05
US10588965B2 (en) 2020-03-17
EP2813230A1 (en) 2014-12-17
EP2453901B1 (en) 2014-09-10
MY164674A (en) 2018-01-30
US20200155672A1 (en) 2020-05-21
US20180264104A1 (en) 2018-09-20
US11135290B2 (en) 2021-10-05

Similar Documents

Publication Publication Date Title
PL3342413T3 (pl) Fukozylolaktoza jako identyczny z mlekiem kobiecym niestrawny oligosacharyd do leczenia i/lub zapobiegania biegunce wirusowej
PH12013500952A1 (en) Oligosaccharide composition for treating acute respiratory tract infections
GB2471806B (en) Compositions and methods for treating viral infections
EP2440251A4 (en) INTERFERON ADMINISTRATION FOR PROPHYLAXIS AGAINST PATHOGEN INFECTION OR TREATMENT OF PATHOGEN INFECTION
ZA201301598B (en) Benzoxaborole derivatives for treating bacterial infections
WO2011056650A9 (en) Methods and compositions for treating and preventing viral infections
IL253038A0 (en) Preparations and methods for the treatment or prevention of infections. my voice
PL2627334T3 (pl) Kompozycje do stosowania w leczeniu zakażeń wirusowych
EP2480255A4 (en) THERAPY FOR ENTERIC INFECTIONS
ZA201005737B (en) Methods of treating viral infections
PL2448438T3 (pl) Otulacz
EP2356236A4 (en) SIRNA COMPOSITIONS AND METHODS FOR HIGHLY INHIBITING VIRAL INFECTION
DK2473482T3 (en) Methods of treating orthomyxoviral infections
PL2424559T3 (pl) Sposoby leczenia zakażeń bakteryjnych z zastosowaniem orytawancyny
IL218286A0 (en) Targeting pax2 for the treatment of breast canecr
EP2624841A4 (en) COMPOSITIONS FOR TREATING CHRONIC VIRAL INFECTIONS
EP2410846A4 (en) GLYCOLIPIDES AS TREATMENT OF DISEASES
PT2725930E (pt) Soluções para esterilização e pasteurização sem molibdatos
ZA201204249B (en) Treatment of microbial infections
ZA201306342B (en) The treatment of viral infections
PH12012500528A1 (en) Compositions and methods for treating bacterial infections using caftaroline
PT2647369T (pt) Pacap para o tratamento de infeções virais em organismos aquáticos
ZA201308116B (en) Avian-based treatment for microbial infections
GB201012168D0 (en) Treatment of viral infections
GB0913914D0 (en) Treatment of viral infections